PMC:7534795 / 7019-7311
Annnotations
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T56 | 25-33 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T57 | 174-182 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T58 | 268-280 | Disease | denotes | hypertension | http://purl.obolibrary.org/obo/MONDO_0005044 |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T62 | 60-76 | Chemical | denotes | N-acetylcysteine | http://purl.obolibrary.org/obo/CHEBI_28939 |
| T63 | 62-76 | Chemical | denotes | acetylcysteine | http://purl.obolibrary.org/obo/CHEBI_22198 |
| T64 | 78-81 | Chemical | denotes | NAC | http://purl.obolibrary.org/obo/CHEBI_28939|http://purl.obolibrary.org/obo/CHEBI_7421 |
| T66 | 90-97 | Chemical | denotes | oxidant | http://purl.obolibrary.org/obo/CHEBI_63248 |
| T67 | 134-137 | Chemical | denotes | NAC | http://purl.obolibrary.org/obo/CHEBI_28939|http://purl.obolibrary.org/obo/CHEBI_7421 |
| T69 | 153-161 | Chemical | denotes | adjuvant | http://purl.obolibrary.org/obo/CHEBI_60809 |
| T70 | 247-250 | Chemical | denotes | NAC | http://purl.obolibrary.org/obo/CHEBI_28939|http://purl.obolibrary.org/obo/CHEBI_7421 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T39 | 60-225 | Sentence | denotes | N-acetylcysteine (NAC) • Anti-oxidant and anti-inflammatory properties of NAC proposed as an adjuvant therapy for COVID-19 and secondary cardiovascular complications |
LitCovid-PD-HP
| Id | Subject | Object | Predicate | Lexical cue | hp_id |
|---|---|---|---|---|---|
| T26 | 268-280 | Phenotype | denotes | hypertension | http://purl.obolibrary.org/obo/HP_0000822 |
2_test
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| 33031856-32252591-84038812 | 54-58 | 32252591 | denotes | 2020 |